In this study, we compared and evaluated antibodies against MBNL1, aiming to identify their recognition sites, assess their ability to detect colocalization with RNA foci observed in DM1, and determine their suitability for immunoprecipitation. This evidence concerns the gene MBNL1 and myotonic dystrophy type 1.